aimkey

Joined 5 years ago

Karma

Submissions

Member since

Jun 22

Recent submissions

You fell for the boondoggle. Waymo has a very narrow set of routes you can take. They collect ultra HD maps for those routes in SF which has a completely unsustainable human labor cost. It doesn’t scale to “drive me on any road”. Waymo is localized-only driving funded at a major loss by a search ads monopoly.

Cruise does the same, just with VC money (and weird low-traffic hours of operation).

They have not solved driving in the generic sense and they are fooling you (and investors)

Comment · 3 years ago

Three specific demographics prefer the (from the factory) higher ride height of SUVs:

1) Women

2) The elderly

3) The overweight

Women have a say in over 70% of vehicle purchases in the US. So even if the vehicle is for dad, mom (who is 5’4” on average) preferring the higher ride height of the SUV will influence the purchase if she has to drive it occasionally.

The elderly and the fat have a harder time getting in and out of lower-riding cars/hatches. The country is getting both older and fatter at the same time.

These are the driving forces in crossover dominance.

Comment · 3 years ago

Their app is a thin wrapper to their mobile site. With Safari push notifications, they don’t need the App Store. I would guess the App Store isn’t a path of discoverability for them anyways. People find them very intentionally on the web.

Comment · 3 years ago

Lock in

Comment · 5 years ago

"Don't take the unproven, unjustified drug" is the default position in medicine. You are trying to shift the burden of proof here and it's embarrassing.

YOU are making at least 3 positive claims when advocating vaccination for those with prior COVID infections:

1) COVID natural immunity breaks historical patterns of natural immunity in similar infectious disease 2) People with "only" natural immunity are at significant risk of severe reinfection 3) There is a risk-adjusted, significant benefit for those with "only" natural immunity to get vaccinated

Comment · 5 years ago

>which confirms my point

lol, no. You know that not a single vaccinated vs unvaccinated population study has ever been conducted, right?

VAERS is designed to detect acute, recent reactions and only acute, recent reactions. If it's not an accute, recent reaction, it probably never makes it into VAERS. That notion that long-term effects could even be reasonably detected today without a vaccinated vs. unvaccinated population study is highly questionable. The CDC refuses to do a vaccinated vs unvaccinated comparison study of overall mortality and disease prevalence. Don't believe me? Go on YouTube and you can find videos of Melinda Wharton making excuses to not do it. Sad, laughable excuses.

Also, you mentioned a German specialist: are you only considering vaccine rollouts in high HDI nations? Because DTP is absolutely associated with increase overall mortality in developing nations. https://pubmed.ncbi.nlm.nih.gov/15082643/

There's also evidence that DTP yields higher mortality in girls: https://academic.oup.com/trstmh/article/110/10/570/2548939

Worth noting that DTP was the reason why the 1986 Vaccine Injury Act was lobbied for and passed in the first place. Vaccines were so "safe", that they couldn't be brought to market for a profit because injuries and lawsuits were so frequent. So, the government indemnified the manufacturers, capped the max injury settlement at $250k, made a special court for vaccine injury where all documents are under seal, and had HHS (taxpayers) make all the payouts. Sounds safe to me!